Protara Therapeutics Inc (TARA)
3.74
+0.03
(+0.81%)
USD |
NASDAQ |
May 16, 16:00
3.71
-0.03
(-0.80%)
After-Hours: 20:00
Protara Therapeutics Enterprise Value: 21.78M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 21.78M |
| May 15, 2024 | 21.17M |
| May 14, 2024 | 13.55M |
| May 13, 2024 | 11.49M |
| May 10, 2024 | 6.547M |
| May 09, 2024 | 6.135M |
| May 08, 2024 | 3.047M |
| May 07, 2024 | 3.870M |
| May 06, 2024 | 4.488M |
| May 03, 2024 | 4.694M |
| May 02, 2024 | 4.282M |
| May 01, 2024 | 5.106M |
| April 30, 2024 | 6.135M |
| April 29, 2024 | 8.57M |
| April 26, 2024 | 4.969M |
| April 25, 2024 | 7.541M |
| April 24, 2024 | 2.808M |
| April 23, 2024 | 6.512M |
| April 22, 2024 | 7.541M |
| April 19, 2024 | -0.896M |
| April 18, 2024 | 1.368M |
| April 17, 2024 | 0.956M |
| April 16, 2024 | 3.425M |
| April 15, 2024 | 3.220M |
| April 12, 2024 | 6.512M |
| Date | Value |
|---|---|
| April 11, 2024 | 8.364M |
| April 10, 2024 | 10.42M |
| April 09, 2024 | -18.41M |
| April 08, 2024 | -16.01M |
| April 05, 2024 | -13.72M |
| April 04, 2024 | -9.259M |
| April 03, 2024 | -8.344M |
| April 02, 2024 | -8.230M |
| April 01, 2024 | -7.887M |
| March 28, 2024 | -19.73M |
| March 27, 2024 | -19.84M |
| March 26, 2024 | -18.13M |
| March 25, 2024 | -19.96M |
| March 22, 2024 | -19.62M |
| March 21, 2024 | -20.99M |
| March 20, 2024 | -19.50M |
| March 19, 2024 | -19.84M |
| March 18, 2024 | -19.84M |
| March 15, 2024 | -23.50M |
| March 14, 2024 | -24.76M |
| March 13, 2024 | -23.85M |
| March 12, 2024 | -24.76M |
| March 11, 2024 | -24.76M |
| March 08, 2024 | -22.13M |
| March 07, 2024 | -22.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-68.94M
Minimum
Nov 09 2022
319.91M
Maximum
Jun 02 2020
6.994M
Average
-20.23M
Median
Feb 20 2024
Enterprise Value Benchmarks
| AngioDynamics Inc | 178.70M |
| Regulus Therapeutics Inc | 33.92M |
| Bio-Path Holdings Inc | 0.5364M |
| Outset Medical Inc | 151.96M |
| AN2 Therapeutics Inc | -46.50M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.10M |
| Total Expenses (Quarterly) | 11.85M |
| EPS Diluted (Quarterly) | -0.97 |
| Earnings Yield | -100.0% |